Article ; Online: Antibody response to 2- and 3-dose SARS-CoV-2 mRNA vaccination in pediatric and adolescent kidney transplant recipients.
Pediatric nephrology (Berlin, Germany)
2022 Volume 38, Issue 2, Page(s) 611–614
Abstract: Background: Additional "booster" doses of mRNA SARS-CoV-2 vaccines have become standard of care for immunosuppressed patients, including kidney transplant recipients (KTR). While these additional doses have been shown to be efficacious in the adult KTR ... ...
Abstract | Background: Additional "booster" doses of mRNA SARS-CoV-2 vaccines have become standard of care for immunosuppressed patients, including kidney transplant recipients (KTR). While these additional doses have been shown to be efficacious in the adult KTR population, there is paucity of data for pediatric and adolescent KTR. Methods: We conducted a retrospective single-center observational study to determine the proportion of pediatric and adolescent KTR who seroconverted following two- and three-dose regimens of an mRNA SARS-CoV-2 vaccine series. Results: Forty-three pediatric and adolescent KTR at our center received at least two doses of an mRNA SARS-CoV-2 vaccine. Seroconversion was noted in 56% of those who received a 2-dose series and increased to 85% in those who received a third dose. In the 16 patients who did not seroconvert after a two-dose series, 12 (75%) seroconverted following the third dose. No serious adverse effects of immunization were noted. Conclusions: Our results demonstrate that additional SARS-CoV-2 vaccine doses are not only safe and efficacious in pediatric and adolescent KTR, but may be necessary to optimize antibody response. A higher resolution version of the Graphical abstract is available as Supplementary information. |
---|---|
MeSH term(s) | Adult ; Humans ; Adolescent ; Child ; Antibody Formation ; COVID-19 Vaccines ; SARS-CoV-2 ; Kidney Transplantation ; Retrospective Studies ; COVID-19 ; Vaccination ; RNA, Messenger ; Transplant Recipients ; Antibodies, Viral |
Chemical Substances | COVID-19 Vaccines ; RNA, Messenger ; Antibodies, Viral |
Language | English |
Publishing date | 2022-06-27 |
Publishing country | Germany |
Document type | Observational Study ; Journal Article ; Research Support, N.I.H., Extramural |
ZDB-ID | 631932-4 |
ISSN | 1432-198X ; 0931-041X |
ISSN (online) | 1432-198X |
ISSN | 0931-041X |
DOI | 10.1007/s00467-022-05661-8 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 2196: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.